Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy

Vascular Health and Risk Management ◽

10.2147/vhrm.s95044 ◽

2017 ◽

Vol Volume 13 ◽

pp. 29-41 ◽

Cited By ~ 9

Author(s):

Nicola Tarantino ◽

Francesco Santoro ◽

Luisa De Gennaro ◽

Michele Correale ◽

Francesca Guastafierro ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Mixed Dyslipidemia ◽

Dose Combination

Download Full-text

Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial

Current Therapeutic Research ◽

10.1016/j.curtheres.2020.100595 ◽

2020 ◽

Vol 93 ◽

pp. 100595

Author(s):

Antonio Carlos Amedeo Vattimo ◽

Francisco Antonio Helfestein Fonseca ◽

Douglas Costa Morais ◽

Larissa Fontes Generoso ◽

Renata Herrera ◽

...

Keyword(s):

Randomized Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Primary Hypercholesterolemia ◽

Multicenter Randomized Trial ◽

Mixed Dyslipidemia ◽

Dose Combination

Download Full-text

Simvastatin Plus Fenofibrate As A Fixed Dose Combination In The Treatment Of Mixed Dyslipidemia In Greece: Budget Impact Analysis

Value in Health ◽

10.1016/j.jval.2014.08.1385 ◽

2014 ◽

Vol 17 (7) ◽

pp. A479

Author(s):

J. Relakis ◽

G. Kourlaba ◽

N. Maniadakis

Keyword(s):

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Mixed Dyslipidemia ◽

Dose Combination

Download Full-text

Comparison of efficacy and safety of fixed dose combination of rosuvastatin and choline fenofibrate to fixed dose combination of rosuvastatin and fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicentre clinical trial in Indian population

Indian Journal of Endocrinology and Metabolism ◽

10.4103/ijem.ijem_321_16 ◽

2018 ◽

Vol 22 (5) ◽

pp. 627

Author(s):

Hanmant Barkate ◽

Piyush Patel ◽

Dimple Shah ◽

Falgun Vyas

Keyword(s):

Clinical Trial ◽

Indian Population ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Open Label ◽

Multicentre Clinical Trial ◽

Mixed Dyslipidemia ◽

Dose Combination

Download Full-text

Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with COPD, stratified by ICS use

Pneumologie ◽

10.1055/s-0036-1572276 ◽

2016 ◽

Vol 70 (S 01) ◽

Cited By ~ 1

Author(s):

ED Bateman ◽

K Chapman ◽

S Rennard ◽

L Rekeda ◽

M Moya ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Dose Combination

Download Full-text

Overall safety and cardiovascular safety of fixed-dose combination of aclidinium/formoterol compared to salmeterol/fluticasone in patients with COPD

Pneumologie ◽

10.1055/s-0036-1572086 ◽

2016 ◽

Vol 70 (S 01) ◽

Author(s):

J Beier ◽

C Vogelmeier ◽

R Mroz ◽

S Pascual ◽

RM Segarra ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Cardiovascular Safety ◽

Dose Combination

Download Full-text

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

Endocrine Abstracts ◽

10.1530/endoabs.49.ep598 ◽

2017 ◽

Author(s):

M G Bubnova ◽

D M Aronov ◽

Marina Bubnoa ◽

David Aronov

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Diseases ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Essential Phospholipids

Download Full-text

135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db20-135-or ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 135-OR

Author(s):

ELENI PAPPA ◽

CHRISTINA KOSTARA ◽

CONSTANTINOS TELLIS ◽

ALEXANDROS D. TSELEPIS ◽

ELENI BAIRAKTARI ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lipoprotein Metabolism ◽

Serum Lipoprotein ◽

Insulin Degludec ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination

Download Full-text

Phase 3 randomized, controlled clinical trial of bictegravir coformulated with FTC/TAF in a fixed-dose combination (B/F/TAF) vs dolutegravir (DTG) + F/TAF in treatment-naïve HIV-1 positive adults: week 48 results

10.26226/morressier.5aeaf2d35800a00019097f85 ◽

2018 ◽

Author(s):

Christian Wisskirchen ◽

Hans-Jürgen Stellbrink

Keyword(s):

Clinical Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Treatment Naïve ◽

Dose Combination ◽

Hiv 1

Download Full-text

A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04024462 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Subcutaneous Administration ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Her2 Positive ◽

Dose Combination

Download Full-text

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed

Case Medical Research ◽

10.31525/ct1-nct04132674 ◽

2019 ◽

Author(s):

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Marginalized Populations ◽

Dose Combination ◽

Tenofovir Alafenamide ◽

Hiv 1

Download Full-text